UK Bionic Eye trial starts for dry AMD patients
The first study that aims to establish whether blind patients
with loss of central vision due todry age-related macular
degeneration (AMD) can benefit from an electronic artificial retina
- the Argus® II retinal prosthesis system - has begun recruiting
patients in the UK after receiving full trial approval. Previously,
this, and the other retinal implants currently available, have been
indicated only for use only in patients with the rare disease
retinitis pigmentosa (RP). This is the first time that a retinal
implant will beused to treat patients with AMD.
The trial, which will take place at Manchester Royal Eye
Hospital, led by Professor Paulo Stanga, was publicised yesterday
on BBC North West Tonight and in the Manchester Evening News.
For the coverage, please go to:
Interested patients can call Danielle Ridyard, research
assistant to Professor Stanga on 0161 701 7691 or email